Category: Joint ventures/collaborations
-
Two Therapies Dropped from NIH Covid-19 Trial
A clinical trial testing multiple treatments for people hospitalized with Covid-19 infections is dropping two therapies for not meeting efficacy standards.
-
Other Vaccinations Shown to Help Prevent Covid-19
An analysis of health records suggests people vaccinated earlier against childhood and adult infectious diseases are also less likely to contract Covid-19.
-
Tech Companies Partner on Covid-19 Breath Test
A maker of diagnostics that examine exhaled breath and an artificial intelligence chip provider are developing a simple breath test for Covid-19 infections.
-
New Trial Testing Reformulated Covid-19 Vaccine
Two drug makers are beginning a clinical trial to test their reformulated vaccine against Covid-19 disease, particularly among older populations.
-
Crispr-Edited Bananas Get Industry Funding
A popular type of banana, genetically edited to resist a soil fungus that threatens this fruit worldwide, is now backed by a major American food brand.
-
Novartis, Gates Partner on Sickle Cell Gene Therapy
Global drug maker Novartis is collaborating with the Bill and Melinda Gates Foundation to find affordable gene therapies for sickle cell disease.
-
Grant Funds Brain Disease Tissue Banks
An advocacy organization for neurodegenerative diseases and medical research foundation are sponsoring formation of a network to collect brain tissue samples.
-
AI Designs Better Gene Therapy Delivery Viruses
An academic-industry team used machine learning to design more effective variations of common benign viruses that deliver gene therapies.
-
AbbVie Licenses Engineered Crispr Cell Process
Drug maker AbbVie is acquiring a technology using the gene-editing process Crispr to produce new off-the-shelf engineered T-cells as disease therapies.
-
$100M Challenge Seeks Carbon Removal Technologies
An XPrize challenge competition, sponsored by Elon Musk, is seeking new technologies that remove large quantities of carbon dioxide from the atmosphere.